Back to search

Article

Periostin: A Biomarker Useful in Treating Patients with Progressive Fibrosing Interstitial Lung Diseases

2021-07-27

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>The concept of progressive fibrosing interstitial lung diseases (PF-ILD) has been recently proposed to describe a progressive phenotype in fibrosing ILDs, separate from the classical differential diagnosis of ILDs. However, we still do not know enough about how we can differentiate PF-ILD patients from non–PF-ILD patients in advance or how we can predict decline...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6dc3a881-bb52-5c6a-8a7e-3d032bf899d0
DOI
10.21203/rs.3.rs-713223/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Periostin: A Biomarker Useful in Treating Patients with Progressive Fibrosing Interstitial Lung DiseasesDOI 10.21203/rs.3.rs-713223/v1
Select a neighboring publication to make it the new centre.